American Heart Association
The latest news from the AHA Scientific Sessions, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention and more.
Related Articles
Author Hub | AHA/ASA Journals
Rigorous, dependable research has always been at the core of the American Heart Association (AHA) mission to be a relentless force for a world of…
GPER Stimulation Attenuates Cardiac Dysfunction in a Rat Model of Preeclampsia | Hypertension
BACKGROUND: Preeclampsia poses a substantial clinical challenge, characterized by maternal hypertension, cardiac dysfunction, and persistent cardiovascular risks for both the mother and offspring. Despite the…
Nearly 400 primary care doctors at Mass General, Brigham and Womenâs hospitals file to unionize
Citing a âcrisisâ in healthcare, nearly 400 primary care physicians at Massachusetts General Hospital and Brigham & Womenâs Hospital are taking steps to unionize, a…
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction
This randomized clinical trial investigates the long-term efficacy of mavacamten in reducing the need for septal reduction therapy in patients with obstructive hypertrophic cardiomyopathy.
The Psychology of Money: Timeless lessons on wealth, greed, and happiness
Quote shared via Kindle: “Nassim Taleb explained: âTrue success is exiting some rat race to modulate oneâs activities for peace of mind.â…
Episode 16: Update from the American Heart Association 2024 Science Meeting from 2024
Podcast Episode ¡ Heart Corner: Innovations in Cardiovascular Science ¡ 11/18/2024 ¡ 20m
AliveCor’s Revolutionary Approach to Heart Monitoring – What’s Up with Tech?
What if you could gain unparalleled insights into heart health from the comfort of your home? Join us as we uncover the incredible journey of…
One in Five Atherosclerotic Cardiovascular Disease Events in Individuals With Diabetes Attributed to Elevated Remnant Cholesterol
Fraction of ASCVD, peripheral artery disease, myocardial infarction and ischaemic stroke attributable to elevated remnant cholesterol in individuals with diabetes from the Copenhagen General Populati…
Safety and Effectiveness of LowâDensity Lipoprotein CholesterolâLowering Therapy With Evolocumab for Familial Hypercholesterolemia/Hypercholesterolemia in Japan: A RealâWorld, Postmarketing, SingleâArm Study | Journal of the American Heart Association
BackgroundEvolocumab is the first monoclonal antibody against proprotein convertase subtilisin/kexin type 9 approved in Japan for familial hypercholesterolemia (FH) and hypercholesterolemia; howeve…
Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients
Lung transplant recipients (LTRs) are susceptible to severe Coronavirus Disease 2019 (COVID-19) and had lower immune responses to primary severe acute respiratory syndrome-related to coronavirus…
